Literature DB >> 17307530

Patent ductus arteriosus: evidence for and against treatment.

Ronald I Clyman, Nancy Chorne.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17307530      PMCID： PMC2723062          DOI： 10.1016/j.jpeds.2006.12.048

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  33 in total

1.  Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.

Authors:  L Mahony; V Carnero; C Brett; M A Heymann; R I Clyman
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

2.  Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants.

Authors:  R B Cotton; M T Stahlman; H W Bender; T P Graham; W Z Catterton; I Kovar
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406

3.  Effects of indomethacin upon cerebral hemodynamics of newborn pigs.

Authors:  C W Leffler; D W Busija; A M Fletcher; D G Beasley; J R Hessler; R S Green
Journal:  Pediatr Res       Date:  1985-11       Impact factor: 3.756

4.  The silent ductus: its precursors and its aftermath.

Authors:  C Hammerman; E Strates; S Valaitis
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

5.  Indomethacin therapy on the first day of life in infants with very low birth weight.

Authors:  L Mahony; R L Caldwell; D A Girod; R A Hurwitz; R D Jansen; J A Lemons; R L Schreiner
Journal:  J Pediatr       Date:  1985-05       Impact factor: 4.406

6.  Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.

Authors:  R M Yanagi; A Wilson; E A Newfeld; K U Aziz; C E Hunt
Journal:  Pediatrics       Date:  1981-05       Impact factor: 7.124

7.  Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.

Authors:  P Kääpä; P Lanning; M Koivisto
Journal:  Acta Paediatr Scand       Date:  1983-03

8.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

9.  Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus.

Authors:  H W Seyberth; W Rascher; R Hackenthal; L Wille
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

10.  Risk factors predicting vasopressor use after patent ductus arteriosus ligation.

Authors:  Furqan Moin; Kathleen A Kennedy; Fernando R Moya
Journal:  Am J Perinatol       Date:  2003-08       Impact factor: 1.862
View more
  37 in total

1.  Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.

Authors:  Jonathan L Slaughter; Patricia B Reagan; Thomas B Newman; Mark A Klebanoff
Journal:  JAMA Pediatr       Date:  2017-03-06       Impact factor: 16.193

2.  Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

Review 3.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

4.  Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone.

Authors:  Elaine L Shelton; Gerren Ector; Cristi L Galindo; Christopher W Hooper; Naoko Brown; Irene Wilkerson; Elise R Pfaltzgraff; Bibhash C Paria; Robert B Cotton; Jason Z Stoller; Jeff Reese
Journal:  Physiol Genomics       Date:  2014-05-01       Impact factor: 3.107

5.  Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.

Authors:  Karen E Corff; Kris C Sekar
Journal:  J Pediatr Pharmacol Ther       Date:  2007-07

Review 6.  Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.

Authors:  Palmer G Johnston; Maria Gillam-Krakauer; M Paige Fuller; Jeff Reese
Journal:  Clin Perinatol       Date:  2012-01-13       Impact factor: 3.430

7.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

8.  Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.

Authors:  Sanju Yadav; Sheetal Agarwal; Arti Maria; Ajay Dudeja; N K Dubey; Puneet Anand; Dinesh Kumar Yadav
Journal:  Pediatr Cardiol       Date:  2014-01-17       Impact factor: 1.655

9.  Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?

Authors:  Xavier Durrmeyer; Shushanik Hovhannisyan; Yves Médard; Evelyne Jacqz-Aigrain; Fabrice Decobert; Jérome Barre; Corinne Alberti; Yannick Aujard; Claude Danan; Olivier Baud
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

Review 10.  Patent ductus arteriosus in preterm infant: Basic pathology and when to treat.

Authors:  Abdulrahman M H Al Nemri
Journal:  Sudan J Paediatr       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.